Literature DB >> 16549399

Delineation of the motor disorder of Lesch-Nyhan disease.

H A Jinnah1, Jasper E Visser, James C Harris, Alfonso Verdu, Laura Larovere, Irene Ceballos-Picot, Pedro Gonzalez-Alegre, Vladimir Neychev, Rosa J Torres, Olivier Dulac, Isabelle Desguerre, David J Schretlen, Kenneth L Robey, Gabor Barabas, Bastiaan R Bloem, William Nyhan, Raquel De Kremer, Gary E Eddey, Juan G Puig, Stephen G Reich.   

Abstract

Lesch-Nyhan disease (LND) is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Affected individuals exhibit over-production of uric acid, along with a characteristic neurobehavioural syndrome that includes mental retardation, recurrent self-injurious behaviour and motor disability. Prior studies involving relatively small numbers of patients have provided different conclusions on the nature of the motor disorder. The current study includes the results of a multi-centre international prospective study of the motor disorder in the largest cohort of patients studied to date. A total of 44 patients ranging from 2 to 38 years presented a characteristic motor syndrome that involved severe action dystonia superimposed on baseline hypotonia. Although some patients also displayed other extrapyramidal or pyramidal signs, these were always less prominent than dystonia. These results are compared with a comprehensive review of 122 prior reports that included a total of 254 patients. Explanations for the differing observations available in the literature are provided, along with a summary of how the motor disorder of LND relates to current understanding of its pathophysiology involving the basal ganglia.

Entities:  

Mesh:

Year:  2006        PMID: 16549399      PMCID: PMC3508431          DOI: 10.1093/brain/awl056

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  84 in total

1.  Lesch-Nyhan syndrome: growth delay, testicular atrophy and a partial failure of the 11 beta-hydroxylation of steroids.

Authors:  R W Watts; R A Harkness; E Spellacy; N F Taylor
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Lesch-Nyhan syndrome: report of two cases.

Authors:  R A Salman; R S Glickman; S Super
Journal:  J Oral Med       Date:  1987 Jan-Mar

Review 3.  Orofacial and other self-mutilations.

Authors:  J Jankovic
Journal:  Adv Neurol       Date:  1988

4.  Hypoxanthine and tetrahydrobiopterin treatment of a patient with features of the Lesch-Nyhan syndrome.

Authors:  H Manzke; H Gustmann; H G Koke; W L Nyhan
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

5.  Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation.

Authors:  M Goldstein; L T Anderson; R Reuben; J Dancis
Journal:  Lancet       Date:  1985-02-09       Impact factor: 79.321

6.  Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations.

Authors:  R W Watts; E Spellacy; D A Gibbs; J Allsop; R O McKeran; G E Slavin
Journal:  Q J Med       Date:  1982

7.  Long-term follow-up of ten patients with Lesch-Nyhan syndrome.

Authors:  T Mizuno
Journal:  Neuropediatrics       Date:  1986-08       Impact factor: 1.947

8.  A female case of the Leach-Nyhan syndrome.

Authors:  K Hara; S Kashiwamata; N Ogasawara; H Ohishi; R Natsume; T Yamanaka; S Hakamada; S Miyazaki; K Watanabe
Journal:  Tohoku J Exp Med       Date:  1982-07       Impact factor: 1.848

9.  Differential diagnosis of cerebral palsy: Lesch-Nyhan syndrome without self-mutilation.

Authors:  G Mitchell; R R McInnes
Journal:  Can Med Assoc J       Date:  1984-05-15       Impact factor: 8.262

10.  Cervical spondylotic radiculo-myelopathy in patients with athetoid-dystonic cerebral palsy: clinical evaluation and surgical treatment.

Authors:  G Hirose; S Kadoya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

View more
  74 in total

1.  Mild Lesch-Nyhan Disease in a Boy with a Null Mutation in HPRT1: An Exception to the Known Genotype-Phenotype Correlation.

Authors:  Allan Bayat; Mette Christensen; Flemming Wibrand; Morten Duno; Allan Lund
Journal:  JIMD Rep       Date:  2014-11-04

2.  Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.

Authors:  Marta G García; Juan G Puig; Rosa J Torres
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

3.  Clinical utility gene card for: Lesch-Nyhan syndrome.

Authors:  Rosa J Torres; Juan G Puig; Irène Ceballos-Picot
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 4.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

5.  Orange-colored diapers as first sign of Lesch-Nyhan disease in an asymptomatic infant.

Authors:  Serena Gasperini; Stefano Stagi; Ugo Gasperini; Renzo Guerrini; Giancarlo la Marca; Maria Alice Donati
Journal:  Pediatr Nephrol       Date:  2010-06-02       Impact factor: 3.714

6.  Chronic peritoneal dialysis in a 4-year-old boy with Lesch-Nyhan disease.

Authors:  Su Jin Kim; Young Bae Sohn; Sung Won Park; Dong-Kyu Jin; Kyung Hoon Paik
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

7.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

8.  Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.

Authors:  Rong Fu; Diane Sutcliffe; Hong Zhao; Xinyi Huang; David J Schretlen; Steve Benkovic; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

Review 9.  Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.

Authors:  Rong Fu; Chung-Jen Chen; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-05-28       Impact factor: 4.797

10.  Skewed X inactivation in Lesch-Nyhan disease carrier females.

Authors:  Rosa J Torres; Juan G Puig
Journal:  J Hum Genet       Date:  2017-09-14       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.